Table 1.

Epidemiological features, clinical manifestation, and laboratory findings of Sweet syndrome patients with sporotrichosis

Case	Gender	Age (years)	Clinical features	Contact with cats	Treatment	Species
1	F	33	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 12 weeks + prednisone 40 mg/day for 7 days	S. brasiliensis
2	M	54	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 12 weeks + prednisone 40 mg/day for 14 days	S. brasiliensis
3	F	53	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 10 weeks + prednisone 40 mg/day for 14 days	S. brasiliensis
4	F	47	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 12 weeks + prednisone 40 mg/day for 10 days	S. brasiliensis
5	M	56	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 16 weeks + prednisone 40 mg/day for 10 days	S. brasiliensis
6	M	66	Fixed cutaneous lesion	No	Terbinafine 250 mg/day for 8 weeks + prednisone 40 mg/day for 30 days	S. brasiliensis
7	F	54	Fixed cutaneous lesion	Yes	Terbinafine 250 mg/day for 8 weeks + prednisone 40 mg two cycles for 10 days	S. brasiliensis
8	M	53	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 12 weeks + prednisone 40 mg/day for 10 days	S. brasiliensis
9	F	59	Multiple inoculation	Yes	Itraconazole 100 mg/day for 10 weeks + prednisone 40 mg/day for 7 days	S. brasiliensis
10	F	51	Fixed cutaneous lesion	Yes	Itraconazole 100 mg/day for 13 weeks + prednisone 40 mg/day for 14 days	S. brasiliensis

F = female; M = male; S. brasiliensis = Sporothrix brasiliensis.